Transforming growth factor beta-SMAD2 signaling and aortic arch development

Area of Science:

• Developmental biology
• Cardiovascular research
• Molecular genetics

Background:

• The remodeling of pharyngeal arch arteries into the asymmetric aortic arch is a complex developmental process.
• Understanding the molecular mechanisms is key to explaining congenital aortic arch malformations.

Purpose of the Study:

• To investigate the role of transforming growth factor beta2 (Tgfbeta2) in aortic arch remodeling.
• To identify molecular pathways involved in Tgfbeta2-dependent arteriogenesis and malformations.

Main Methods:

• Utilizing Tgfbeta2 knockout mouse models to study aortic arch development.
• Analyzing gene expression patterns, apoptosis, and signaling pathways (e.g., SMAD2).
• Correlating molecular findings with observed aortic arch and intracardiac malformations.

Main Results:

• Tgfbeta2 deficiency leads to aberrant apoptosis in the fourth pharyngeal arch arteries, causing type B interruption and aberrant right subclavian artery.
• Reduced vascular SMAD2 signaling and altered expression of fibronectin and neural cell adhesion molecule in the fourth arch arteries.
• A link between neural crest cell contribution, vascular signaling, and arteriogenesis is established.

Conclusions:

• Selective apoptosis in the fourth pharyngeal arch arteries, regulated by Tgfbeta2, is essential for normal aortic arch formation.
• Disturbances in Tgfbeta2 signaling impact arteriogenesis and innervation, contributing to congenital malformations.
• Both neural crest and hemodynamic factors likely interplay in Tgfbeta2-related cardiovascular defects.